Literature DB >> 23131394

Local thrombolysis for patients of severe cerebral venous sinus thrombosis during puerperium.

Xin-Bin Guo1, Zhenqiang Fu, Lai-Jun Song, Sheng Guan.   

Abstract

OBJECTIVE: To explore and evaluate the efficacy of intrasinus thrombolysis (IST) in patients with cerebral venous sinus thrombosis (CVST) during postpartum period.
METHODS: 11 patients during postpartum period with CVST who received IST during July 2007-November 2011 were included. Urokinase was infused into the sinuses via a microcatheter. Magnetic resonance venography (MRV) was performed to assess the recanalization of venous sinuses.
RESULTS: Before discharge, the intracranial pressure in 11 patients was under 200 mmH(2)O. MRV confirmed that venous sinus of 9 patients were smooth. The cortex venous and deep venous recovered to normal. Venous sinus of 2 patients recanalized partly, and cortex venous and deep venous had compensation. 9 patients had good outcome and 2 patients had only mild deficits.
CONCLUSION: Intrasinus thrombolysis is safe and effective in patients with severe cerebral venous sinus thrombosis during postpartum period.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131394     DOI: 10.1016/j.ejrad.2012.07.019

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

Review 1.  Endovascular treatments for cerebral venous sinus thrombosis.

Authors:  Zhongming Qiu; Hongfei Sang; Qiliang Dai; Gelin Xu
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

2.  A case of cerebral venous sinus thrombosis associated with Crohn's disease: dilemma in management.

Authors:  Younghoon Kwon; Ryan J Koene; Yeilim Cho
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-11-10

Review 3.  Cerebral sinus venous thrombosis.

Authors:  Hernando Raphael Alvis-Miranda; Sandra Milena Castellar-Leones; Gabriel Alcala-Cerra; Luis Rafael Moscote-Salazar
Journal:  J Neurosci Rural Pract       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.